Onur Ertunc

7PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmacogenomicsInnate immunityMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 14, 2024
Potential Hepatoprotective Effects of Irbesartan, an Accessible Angiotensin II Receptor Blocker, Against Cisplatin-Induced Liver Injury in a Rat Model.

Onur Ertunç, Yalçın Erzurumlu, Mehtap Savran

|Jul 17, 2023
The Importance of Prostate-Specific Membrane Antigen Expression in Salivary Gland Tumors.

Mehmet Emre Sivrice, Hasan Yasan, Yusuf Çağdaş Kumbul

|Feb 21, 2022
Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer.

Busra Ozbek, Onur Ertunc, Andrew Erickson

|Feb 08, 2022
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource.

Véronique Ouellet, Andrew Erickson, Kathy Wiley

|Jun 04, 2021
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance.

Juan M Arriaga, Sukanya Panja, Mohammed Alshalalfa

Pageof 2